Figure. Downtown Nashville.

We are excited to announce that the SUFU (Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction) winter meeting will be held on March 7-11, 2023, in Music City—Nashville, Tennessee—at the Grand Hyatt Nashville! The meeting has a mix of basic science talks, informative thought-provoking poster and podium presentations, insightful discussion during debates and breakout sessions, networking, empowering Zumba, clinical pearls, useful updates, camaraderie, and fun for both the general urologist as well as specialists in urodynamics, incontinence, female pelvic medicine, neurourology, and urogenital reconstructive surgery. After the meeting, grab your cowboy boots and head downtown for live music matched with “holler and swaller” (also known as yeehaw and take a big swig).

Meeting highlights include updates on the basic science behind neural engineering and regenerative medicine, a panel on machine learning in Female Pelvic Medicine and Reconstructive Surgery (FPMRS), challenging treatment debates, surgical pearls, awards, a focus on DEI (Diversity, Equity, and Inclusion) and wellness, discussions about social media, an American Board of Urology update, increased time for panel and audience discussions, and an increased number of breakout sessions. As usual, there will be video, moderated podium, and poster sessions focused on incontinence, neurogenic bladder, basic science, pelvic organ prolapse, reconstruction, neuromodulation, benign prostatic hyperplasia (BPH), interstitial cystitis, and geriatrics. This year’s meeting also features some great opportunities for fellows and residents to network.

Some of the basic science talks at this year’s meeting that would interest all urologists include a tribute to the legacy of the late surgeon-scientist Dr Phil Smith and a keynote lecture on regenerative medicine. An expert panel will be discussing advances in imaging for both research and clinical implications. The Thursday morning program will focus on translational research, including a discussion about machine learning in FPMRS, and an Early Investigator Spotlight to provide an opportunity for early-career researchers to discuss their translational work.

In order to facilitate discussion and interactions, there will be an expanded number of breakout sessions held during the program. Breakout topics will include Burnout/Wellness, Optimization of Advanced Practice Provider Practices in FPMRS, Diversity on the Job, Advanced Urodynamics, Establishing a Successful Academic FPMRS Practice (in Academic Settings and in Nonacademic Settings), and Complex Clinical Cases.

This year’s program includes a series of expert panels, with more time devoted to in-depth discussion and audience participation than in the past. Please come prepared to interact with the panelists and ask them questions or provide your own perspectives!

• The numerous procedures that are available to treat BPH/lower urinary tract symptoms can make it confusing to determine the optimal treatment for an individual patient. A panel on BPH procedures will be chaired by Lori Lerner, MD, and will discuss the advantages and disadvantages of transurethral resection of the prostate, Rezu–m/Aquablation, holmium laser enucleation of the prostate, and UroLift (panelists Joshua Cohn, MD, Christopher Tenggardjaja, MD, Nicole Miller, MD, and Alvaro Lucioni, MD).
• Treatment options for sacral neuromodulation continue to evolve, and this will be reviewed during a panel discussion on New Developments in Sacral Neuromodulation (Priyanka Gupta, MD, moderator). Topics will include coding changes (Brook Brown, MD, MPH), technological advancements (Chris Chermansky, MD), patient selection (Ben Brucker, MD), and technical considerations/battery programming (Bradley Gill, MD, MS).
• There is increasing awareness of the risk of anticholinergic medications, especially in the elderly, and yet these medications are commonly mandated as first-line medical therapy by insurance coverage limitations. The Role of Beta-3 Agonists in the Treatment of Overactive Bladder will be discussed by Howard Goldman, MD, FACS (panelists Anne Suskind, MD, MS, FACS, Blayne Welk, MD, and Christopher Elliott, MD, PhD).
• The importance of creating an inclusive environment for our FPMRS patients will be highlighted by an interactive panel which will review challenges unique to our patients from differing backgrounds, including race/ethnicity, LGBTQ+, socioeconomic status, and disabilities (moderator Tracey Wilson, MD, panelists Yahir Santiago-Lastra, MD, Jennifer Anger, MD, MPH, Nitya Abraham, MD, and Sara Lenherr, MD, MS).
• Social media engagement is a potentially powerful tool to enhance an FPMRS practice, but users should also be aware of its drawbacks. The pearls and pitfalls of social media will be reviewed and discussed by Una Lee, MD (moderator), Seth Cohen, MD, FACS, and Rena Malik, MD.
• Multiple agents are now U.S. Food and Drug Administration approved for periurethral injections for the treatment of female stress urinary incontinence (SUI). The role of periurethral injection therapy for SUI (including potential off-label uses) will be summarized by Tracey Wilson, MD, FACS, and Donna Deng, MD, MS (moderated by Brian Linder, MD).
• FPMRS outcomes are frequently overlooked in female patients considering radical cystectomy. These outcomes (SUI, urinary retention, sexual function, pelvic organ prolapse, etc) will be discussed by Ariana Smith, MD, Polina Reyblat, MD, Lee Richter, MD, and Sandip Vasavada, MD.
• Finally, an Expert Surgical Theater (moderated by Jaspreet Sandhu, MD) will focus on complex abdominal reconstruction, including continent catheterizable channels (Rose Khavari, MD), ureteral strictures after urinary diversion (Lenaine Westney, MD), and stoma complications (John Stoffel, MD).

We hope to see you all there in Nashville!